Blood biomarkers, such as carbohydrate antigens 15-3 (CA15-3), carcinoembryonic antigen (CEA), CA 27.29, HER2/neu, and CTCs, are primarily used to clinically assist in diagnosis and monitor the response to the treatment or recurrence of breast cancer [93–96]. Here, ERBB2 is linked to breast carcinoma.